What The Study Did: Researchers describe the assessment and immunization of highly allergic individuals with the Pfizer-BioNTech COVID-19 vaccine, as well as the rate of adverse reactions to the vaccine in this population.
Authors: Nancy Agmon-Levin, M.D., of the Sheba Medical Center in Tel Hashomer, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.22255)
Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.22255?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083121
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open